2496 fundamentals
An in-depth look to WUHAN YZY BIOPHARMA CO. LTD. operating, investing, and financing activities
2496 free cash flow for H2 24 is -48.61 M HKD. For 2024, 2496 free cash flow was -112.46 M HKD and operating cash flow was -110.82 M HKD.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM